Our products will initially target the point-of-care (POC) and physician’s office laboratory (POL) market segments within the domestic and international in vitro diagnostics device market, with expansion predicted into retail pharmacy/over-the-counter (OTC), clinical labs, and Health Care Associations. Our customers will include physicians, hospitals, emergency rooms, wholesale distributors, and pharmacies.

 

Market Strategy

Our products have been designed to offer a clear-cut differentiation with currently available tests for monitoring diabetes, kidney function and coagulation.

• Lower cost

• User convenience

• Value of information

• Facilitation of doctor-patient feedback

• Therapeutic intervention